Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Elkem takes 100% ownership of Salten energy recovery plant

Elkem has today secured 100% ownership of the Elkem Salten energy recovery plant, after acquiring the remaining 50% stake from Kvitebjørn Energi. The transaction is attractive to Elkem and provides increased strategic flexibility.On 15 November, Prime Minister Jonas Gahr Støre opened the new energy recovery plant at Elkem Salten in the northern part of Norway. The energy recovery plant is closely integrated with the silicon production process at Elkem Salten, utilizing the excess heat from the silicon furnaces to produce electrical power. The plant recovers 28% of the electrical energy used

John Mattson takes possession of properties in Gullmarsplan and completes a non-cash issue

John Mattson’s Board of Directors has resolved to carry out a non-cash issue as part payment for the acquisition properties in Gullmarsplan. Possession of the properties will be taken on 1 February.On 12 November 2021, John Mattson announced it had entered into an agreement to acquire properties in Gullmarsplan, Stockholm, with an underlying property value of SEK 670 million before deduction of 25% for latent tax. The acquisitions are being financed through a combination of cash and newly issued shares. As part payment of the purchase price of the shares, John Mattson’s Board of Directors,

The Nomination Committee’s proposal to the Annual General Meeting 2022

STOCKHOLM, February 1[st], 2022. Moberg Pharma AB (OMX: MOB) announces that the company’s Nomination Committee has decided to present the following proposal to the Annual General Meeting 2022.The Nomination CommitteeThe Nomination Committee consists of the Chairman Gillis Cullin representing Östersjöstiftelsen and the members Anders Lundmark, Martin Öhrn and Peter Wolpert, Chairman of the Board of Directors in the Company. Chairman of the Annual General MeetingThe Nomination Committee proposes that Peter Wolpert is elected as Chairman of the Annual General Meeting of shareholders

Musti Group will publish its Interim Report for October 2021 – December 2021 on Tuesday, 8 February 2022

Musti Group plc                        Press Release 1 February 2022 at 9.00 a.m. Musti Group will publish its Interim Report for October 2021 – December 2021 on Tuesday, 8 February 2022 Musti Group will publish its Interim Report for October 2021 – December 2021 on Tuesday, 8 February 2022 at 8:30 a.m. EET. The report will be available at https://www.mustigroup.com/investors/reports-and-presentations/ after publication. A webcast and international telephone conference for analysts and media will be arranged on the publishing day at 2:00 p.m. EET. The event will be held in English.

Nurminen Logistics Plc to issue new shares in the company to the company itself without consideration

Nurminen Logistics Plc                            Stock Exchange Release February 1, 2022, at 9.00 a.m.  The Board of Directors of Nurminen Logistics Plc (the “Company”) has, pursuant to the authorization granted to it by the Annual General Meeting held on 12 April 2021, yesterday evening resolved to issue 774 386 new shares in the Company to the Company itself without consideration in accordance with Chapter 9, Section 20 of the Finnish Companies Act (624/2006, as amended). The new shares to be issued are of the same class as the existing shares in the Company. The total number of the

SNIFFIE SECURED A 2.5M€ FUNDING FOR ECOMMERCE PRICING AUTOMATION

Price became a silent megatrend in ecommerce. The ability for consumers to compare prices, the amount of brand owners selling their products online, and the abilities big ecommerce companies have to use data and machine learning is something we’ve never seen before. Profitable pricing has become a burning problem for small & mid-sized ecommerce businesses. The vision of Sniffie , a startup from Helsinki, Finland is to democratize ecommerce by enabling the equal use of machine learning in pricing for small and mid-sized ecommerce businesses. To reach this goal,

The Nomination Committee’s proposal for Board of Directors of Indutrade AB for the 2022 AGM

The Nomination Committee proposes re-election of Katarina Martinson as Chairwoman of the Board at the 2022 Annual General Meeting. The Committee also proposes the re-election of Board members Susanna Campbell, Bengt Kjell, Anders Jernhall, Ulf Lundahl, Krister Mellvé, Lars Pettersson and Bo Annvik. Provided that the Annual General Meeting resolves to amend the articles of association to allow for additional members, it is also proposed to elect Kerstin Lindell as new Board member. Kerstin Lindell was born in 1967, is an Honorary Doctor at the Faculty of Engineering, LTH and holds a PhD.

Q-Free: Tolling ARR contract in Europe – 120 MNOK

A European tolling operator has awarded Q-Free a contract to design, deliver and maintain tolling roadside equipment. It is mainly structured as a service delivery and will generate annual recurring revenues of 8 MNOK over an expected period of 15 years. System deliveries will start in 2022 and be completed in 2023. The customer has for operational reasons requested to remain anonymous until the project delivery will commence, hence more details about the project will be provided at a later point in time. -This represents a key win for Q-Free in a very important market. It further

Hemnet Group Interim report Q4 2021

Strong growth in net sales and adjusted EBITDASummary for the period October-December 2021 · Net sales increased 24.2 percent to SEK 177.3m (142.7) · Adjusted EBITDA increased 76.3 percent to SEK 84.6m (48.0) · Operating profit increased 175.3 percent to SEK 64.7m (23.5) · ARPL, average revenue per listing, increased 45.0 percent to SEK 3,029 (2,089) Summary for the period January-December 2021 · Net sales increased 33.8 percent to SEK 728.1m (544.1) · Adjusted EBITDA increased 75.7 percent to SEK 355.0m (202.1) · Operating profit increased 102.6 percent to SEK

Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer

Lund, Sweden, February 1, 2022 – Alligator Bioscience (Nasdaq Stockholm: ATORX) Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces the appointment of Sumeet Ambarkhane, MD, as its Chief Medical Officer. In this role, Sumeet will provide medical leadership and direction in the development of Alligator’s best-in-class preclinical and clinical pipeline, including Alligator’s lead assets mitazalimab, a CD40 agonist currently in Phase II clinical development, and ATOR-1017, a 4-1BB agonist in Phase I.    Sumeet is a seasoned professional with over 20 years of drug development

AcadeMedia’s interim report July – December 2021

Second quarter (October – December 2021) · Net sales increased by 9.8 percent and amounted to SEK 3,774 million (3,436). Organic growth, including bolt-on acquisitions, was 6.0 percent. · Operating profit (EBIT) amounted to SEK 342 million (273). · Adjusted operating profit, adjusted for items affecting comparability and effects of IFRS 16, amounted to SEK 263 million (224). Items affecting comparability amounted to SEK 7 million (-9) and include insurance compensation received in relating to a fire in a compulsory school in the first quarter and VAT-expenses relating to the

Össur hf: Interim Report Q4 & FY 2021

Announcement no. 03/2022 Interim report Q4 & FY 2021 1 February 2022 Jon Sigurdsson, President & CEO, comments: “The results for the fourth quarter were solid with especially strong growth in EMEA and APAC. Prosthetics growth was strong in all regions, including Bionics, which has been more affected in prior quarters. This reconfirms our belief that the demand for our advanced and innovative technological solutions remains as we continue to create a Life Without Limitations® for our end-users. We have taken on challenges presented by the COVID-19 pandemic throughout the year and

Implantica Taps Former Medtronic Executive Paul Mead for COO Role

Implantica AG (publ), an emerging and fast growing med-tech company that is pioneering innovative solutions to treat chronic health conditions, announces the appointment of Paul Mead as Chief Operating Officer. Paul brings nearly 20 years of diverse experience at Medtronic to Implantica, having most recently led several Operating Units as Vice President Europe, with additional responsibility spanning EMEA, LATAM and Canada. This appointment further strengthens Implantica’s senior leadership team which is well-balanced and draws from industry leaders.At Medtronic, Paul held positions of

Bonava sells 53 rental apartments in Helsinki

Bonava is selling 53 rental apartments in Helsinki, Finland, to the investor Sirius Capital Partners. The transaction amounts to EUR 16 million and the first housing units are expected to be completed and handed over to the customer in the second quarter of 2023.– We started the collaboration with Sirius Capital Partners in 2021 when they entered the residential sector. We are now very pleased to conclude our second contract with them, says Riku Patokoski, Business Unit President, Bonava Finland. The neighbourhood in question is located in Vuosaari, east Helsinki, a short walk from the

GomSpace (provider of nanosatellites) announces its quarterly results for the fourth quarter 2021

Stockholm, February 1, 2022. GomSpace Group AB (the “Company”) announces its interim report for the fourth quarter of 2021. The report is available on the Company’s homepage (www.gomspace.com). The following is taken from the quarterly report: Fourth quarter summary 1 October – 31 December 2021 (2020) · Order intake increased to T.SEK 286,667 (73,441) · Net revenues increased to T.SEK 81,125 (72,256) · Gross margin increased to 38% (33%) · Operating profit (EBIT) increased to T.SEK 3,473 (310)  · Earnings per share were SEK 0.10 (a negative 0.08) 1 January – 31

Inzile’s Principal Shareholder comments on recent leadership changes

eFashion Championship PTE Ltd (“eFC”) is proposed to join Inzile’s Board of Directors, as a proprietary member, at the Extraordinary General shareholders’ Meeting on February 18, 2022. Enrique Bañuelos, Juan Carlos del Rio and Gloria Bañuelos are proposed by eFC to become part of Inzile’s Board of Directors. This shows the full support and commitment of the eFC Group to develop the company towards a global player in electric mobility solutions.  Board Member Måns Sjöstedt is appointed CEO of Inzile, as it is important for Inzile to have a strong local CEO in Sweden. The former CEO

Finnish startup Jobilla raises €8.25M to build a candidate-driven recruiting funnel that competes in a league of its own

With funding from Juuri Partners and Trind VC, Jobilla can offer its AI-powered recruiting platform to more companies battling with the Great Resignation and War for Talent.Finnish talent acquisition startup Jobilla  has announced the successful closure of an €8.25M funding round led by venture capital investors Juuri Partners  and Trind VC . Jobilla has disrupted recruiting across five different continents by building a recruitment solution where each step of the candidate’s experience is analyzed and optimized to

Oncorena Initiates the Phase I-II Clinical Trial with Orellanine in Advanced Kidney Cancer Patients at Karolinska University Hospital in Sweden

LUND, SWEDEN, February 1, 2022 – Oncorena today announced the initiation of the Phase I-II clinical trial of the first-in-class compound orellanine in patients with advanced kidney cancer on dialysis. The company is dedicated to developing a unique and potential breakthrough therapy for advanced kidney cancer.The drug candidate orellanine, which has an unique mode of action, is being developed for organ-specific chemotherapy with curative potential for patients with advanced kidney cancer undergoing dialysis due to kidney failure. Preclinical evidence shows that orellanine specifically

Sabis chooses Sickla for its new food store

Atrium Ljungberg has signed a lease contract for more than 1,700 m[2] with Sabis, which is going to be expanding and will open a new food store inside the shopping centre Sickla Galleria. The store is part of Sabis’ partnership with Axfood and is going to be called ‘Hemköp Sickla’.Sabis is a family company based in Stockholm that was founded in 1874. It now has 20 restaurants, ten cafes, three hotels and five food stores, including Sabis Fältöversten and four Hemköpsbutiker stores. Its new store in Sickla will be at the western entrance to the shopping centre, next to Curanten, the new

Salmon Evolution ASA: Invitation to presentation of fourth quarter 2021 results

Salmon Evolution will present its fourth quarter 2021 results, followed by a Q&A session, on Thursday, February 10, 2022 at 8:00 a.m. CET. The webcast and subsequent Q&A will be held in English by CEO, Håkon André Berg and CFO, Trond Håkon Schaug-Pettersen. The presentation can be accessed at www.salmonevolution.no, or with the following link: https://streams.eventcdn.net/salmonevolution/2021q4/

Skanska divests the office properties West Memorial I and II in Houston, USA, for USD 147M, about SEK 1.3 billion

Skanska divests the office properties at West Memorial Place I and II in Houston, Texas, USA, for approximately USD 147M, about SEK 1.3 billion, to a joint venture spearheaded by Fuller Realty Interests, LLC. The transaction will be recorded by Skanska USA Commercial Development in the first quarter 2022.West Memorial Place is a 713,000-square feet two building, LEED Platinum office campus located in Houston’s Energy Corridor. West Memorial Place I consists of 331,000 square feet of office space and West Memorial Place II is comprised of 382,000 square feet of office. An early adopter of

Full year and fourth quarter 2021 report

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announces its consolidated results for the full year and fourth quarter 2021.CEO Comment- 2021 was a good year for Tele2 in several ways. As business progressed over the year, we were able to lift our guidance and we are now pleased to announce that we have delivered on these increased targets and that we have created a business that enables us to reiterate our mid-term targets. Further, the Board of Directors has proposed an ordinary dividend of SEK 6.75 per share, a 12.5% increase from last year. We are

Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration

Targovax has entered into a research collaboration with Prof. Michael Uhlin at Karolinska Institutet to develop and characterize novel ONCOS delivery vectorsOslo, Norway, 1 February 2022 – Targovax ASA (OSE: TRVX), a clinical-stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, today announces that it has entered into a two-year research collaboration with Prof. Michael Uhlin of the Department of Clinical Science, Intervention and Technology at Karolinska Institutet in Stockholm, Sweden, to develop and characterize novel ONCOS oncolytic viruses.

Josemaria Share Capital and Voting Rights Update

VANCOUVER, BC, January 31, 2022 /CNW/ - Josemaria Resources Inc. (TSX: JOSE) (OMX: JOSE) (OTCQB: JOSMF) ("Josemaria Resources" or the "Company") reports that, in accordance with the Swedish Financial Instruments Trading Act, as a result of the issuance of common shares pursuant to the terms of previously announced credit facilities during the month of January, 2022, the number of issued and outstanding shares of the Company has increased to 381,835,940 common shares with voting rights as at January 31, 2022.   Additional Information This is information that the Company is obliged

There are no items matching the current filter
There are no more items matching the current filter
Back to top